Prognosis After Pathologic Complete Response to Neoadjuvant Therapy in Early-Stage Breast Cancer: A Population-Based Study
In this population-based study, our findings suggest that patients achieving pCR after NACT are a heterogeneous group in terms of long-term prognosis. Baseline tumor characteristics should be considered when investigating post-neoadjuvant therapy approaches.
Authors
- Caroline Boman (ORCID: https://orcid.org/0000-0003-1663-6129)
- Xingrong Liu (ORCID: https://orcid.org/0000-0003-0199-0221)
- Alexios Matikas (ORCID: https://orcid.org/0000-0002-4122-9624)
- Theodoros Foukakis (ORCID: https://orcid.org/0000-0001-8952-9987)
- Jonas Bergh (ORCID: https://orcid.org/0000-0001-5526-1847)
- Maria Angeliki Toli (ORCID: https://orcid.org/0000-0002-3150-0062)
- Christian Tranchell
- Louise Eriksson Bergman
Institutions
- Karolinska Institutet (SE)
- Saint Göran Hospital (SE)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-12
- DOI
- https://doi.org/10.6004/jnccn.2024.7093
- Citations
- 4
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.75